Exigent Capital

RenalGuard Solutions, Inc. manufactures medical devices focused on cardiac and vascular markets, specifically aimed at preventing contrast-induced nephropathy (CIN) in at-risk patients undergoing imaging procedures. The company's primary product, RenalGuard, is designed to remove toxic contrast dyes from the kidneys and facilitate fluid balancing. It includes the RenalGuard Therapy, which helps mitigate the harmful effects of contrast media, and the RenalGuard System, comprising a console and a single-use set for infusion and urine collection. RenalGuard is already approved for sale in the European Union and has shown effectiveness in preventing CIN through various studies. The device is currently undergoing a pivotal trial in the United States for FDA approval. RenalGuard Solutions sells its products through a network of distributors domestically and internationally, and the company is headquartered in Milford, Massachusetts.

MaxQ-AI utilizes advanced cognitive analytics and artificial intelligence to deliver real time decision support tools to improve clinical outcomes in acute medical scenarios. The MaxQ team of artificial intelligence, machine learning, deep learning and algorithmic experts and its medical advisory boards in Israel and the United States are achieving breakthroughs in standards of cost and care.

RenalGuard Solutions, Inc. manufactures medical devices focused on cardiac and vascular markets, specifically aimed at preventing contrast-induced nephropathy (CIN) in at-risk patients undergoing imaging procedures. The company's primary product, RenalGuard, is designed to remove toxic contrast dyes from the kidneys and facilitate fluid balancing. It includes the RenalGuard Therapy, which helps mitigate the harmful effects of contrast media, and the RenalGuard System, comprising a console and a single-use set for infusion and urine collection. RenalGuard is already approved for sale in the European Union and has shown effectiveness in preventing CIN through various studies. The device is currently undergoing a pivotal trial in the United States for FDA approval. RenalGuard Solutions sells its products through a network of distributors domestically and internationally, and the company is headquartered in Milford, Massachusetts.

StorePower Inc. is a Chicago-based company that provides an online supermarket platform designed to streamline the grocery shopping experience. Established in 2015 as a subsidiary of Direct Eats, Inc., StorePower offers a comprehensive range of services through its Software as a Service (SaaS) model. The platform facilitates various aspects of online retailing, including picking, packing, payment processing, click-and-collect options, and delivery management. Additionally, StorePower's system features automatic stock updates and data analysis tools that help grocery chains optimize their online operations and better understand shopping traffic. With its focus on creating efficient and customized solutions, StorePower aims to enhance the online grocery shopping experience for both retailers and consumers.

Revelator Limited, founded in 2013 and based in Jerusalem, Israel, offers comprehensive business and marketing solutions tailored for music professionals. The company's platform integrates various functions such as sales, marketing, accounting, and analytics, serving both independent artists and record labels. Revelator employs a data-driven fintech approach to revolutionize music intellectual property management, utilizing artificial intelligence and machine learning to streamline the forecasting, settlement, and payment of royalties. By modernizing copyright administration, Revelator enables creators and rights holders to register their works, license rights, manage revenue splits seamlessly, and receive real-time royalty payments directly to digital wallets. The company aims to create a more efficient connection between artists and fans while providing a robust marketplace for financial services related to music royalties and digital collectibles.

Founded in 2006, ImmunArray is a molecular diagnostics company that developed a proprietary test to rule out the presence of the autoimmune disease lupus in blood samples. The test, which ImmunArray introduced last year, is significant because lupus is difficult to diagnose and can be mistaken for other autoimmune diseases. ImmunArray’s test helps avoid incorrect diagnosis and medication.

Liberty SBF Holdings, LLC is a commercial real estate finance company based in Wynnewood, Pennsylvania, with additional operations in Newport Beach, California. Founded in 2011, the company specializes in small-balance commercial lending, catering to small businesses navigating a difficult credit landscape. Liberty SBF provides a diverse range of loan products, including SBA 504 and 7a loans, owner-occupied commercial real estate loans, bridge loans, and various financing options for properties such as offices, retail spaces, industrial sites, hotels, and assisted living facilities. Additionally, the company offers lender services to banks, credit unions, and loan investors, including loan screening, packaging, underwriting, closing, servicing, and mortgage banking services. By utilizing conventional, CMBS, and government-guaranteed loan programs, Liberty SBF aims to support borrowers in their efforts to expand their businesses and acquire commercial real estate.

MaxQ-AI utilizes advanced cognitive analytics and artificial intelligence to deliver real time decision support tools to improve clinical outcomes in acute medical scenarios. The MaxQ team of artificial intelligence, machine learning, deep learning and algorithmic experts and its medical advisory boards in Israel and the United States are achieving breakthroughs in standards of cost and care.